Free Trial
NASDAQ:PROF

Profound Medical (PROF) Stock Price, News & Analysis

Profound Medical logo
$6.74 +0.28 (+4.33%)
Closing price 04:00 PM Eastern
Extended Trading
$6.80 +0.05 (+0.82%)
As of 04:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Profound Medical Stock (NASDAQ:PROF)

Advanced

Key Stats

Today's Range
$6.07
$6.88
50-Day Range
$3.87
$6.46
52-Week Range
$3.76
$9.17
Volume
188,602 shs
Average Volume
86,771 shs
Market Capitalization
$203.01 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$11.00
Consensus Rating
Hold

Company Overview

Profound Medical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
27th Percentile Overall Score

PROF MarketRank™: 

Profound Medical scored higher than 27% of companies evaluated by MarketBeat, and ranked 810th out of 942 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Profound Medical has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, no hold ratings, and 1 sell rating.

  • Upside Potential

    Profound Medical has a consensus price target of $11.00, representing about 61.6% upside from its current price of $6.81.

  • Amount of Analyst Coverage

    Profound Medical has only been the subject of 1 research reports in the past 90 days.

  • Read more about Profound Medical's stock forecast and price target.
  • Earnings Growth

    Earnings for Profound Medical are expected to grow in the coming year, from ($1.12) to ($0.78) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Profound Medical is -4.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Profound Medical is -4.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Profound Medical has a P/B Ratio of 3.39. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Profound Medical's valuation and earnings.
  • Percentage of Shares Shorted

    2.30% of the outstanding shares of Profound Medical have been sold short.
  • Short Interest Ratio / Days to Cover

    Profound Medical has a short interest ratio ("days to cover") of 6.4.
  • Change versus previous month

    Short interest in Profound Medical has recently increased by 0.26%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Profound Medical does not currently pay a dividend.

  • Dividend Growth

    Profound Medical does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.30% of the outstanding shares of Profound Medical have been sold short.
  • Short Interest Ratio / Days to Cover

    Profound Medical has a short interest ratio ("days to cover") of 6.4.
  • Change versus previous month

    Short interest in Profound Medical has recently increased by 0.26%, indicating that investor sentiment is decreasing.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Profound Medical this week, compared to 2 articles on an average week.
  • Search Interest

    12 people have searched for PROF on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Profound Medical insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 1.52% of the stock of Profound Medical is held by insiders.

  • Percentage Held by Institutions

    47.86% of the stock of Profound Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Profound Medical's insider trading history.
Receive PROF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Profound Medical and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PROF Stock News Headlines

U.S. Government Blocked NVIDIA’s Buyout… Here’s Why
The U.S. government doesn't normally block billion-dollar tech deals. But when NVIDIA tried to acquire this tiny supplier, the FTC slammed the door. Why?tc pixel
Profound Medical: Expectations Worsen
See More Headlines

PROF Stock Analysis - Frequently Asked Questions

Profound Medical's stock was trading at $7.51 at the start of the year. Since then, PROF shares have decreased by 9.3% and is now trading at $6.8080.

Profound Medical (NASDAQ:PROF) posted its earnings results on Thursday, August, 14th. The company reported ($0.52) earnings per share for the quarter, missing the consensus estimate of ($0.43) by $0.09. The firm earned $2.21 million during the quarter, compared to analyst estimates of $4.75 million. Profound Medical had a negative trailing twelve-month return on equity of 89.74% and a negative net margin of 343.97%.
Read the conference call transcript
.

Shares of PROF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Profound Medical investors own include Alibaba Group (BABA), Pfizer (PFE), NVIDIA (NVDA), PayPal (PYPL), Tesla (TSLA) and Docusign (DOCU).

Company Calendar

Last Earnings
8/14/2025
Today
10/08/2025
Next Earnings (Estimated)
11/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:PROF
CIK
1628808
Employees
150
Year Founded
2008

Price Target and Rating

High Price Target
$11.00
Low Price Target
$11.00
Potential Upside/Downside
+61.6%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.46)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$27.82 million
Net Margins
-343.97%
Pretax Margin
-343.61%
Return on Equity
-89.74%
Return on Assets
-73.06%

Debt

Debt-to-Equity Ratio
0.11
Current Ratio
8.53
Quick Ratio
7.07

Sales & Book Value

Annual Sales
$10.68 million
Price / Sales
19.20
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.01 per share
Price / Book
3.39

Miscellaneous

Outstanding Shares
30,120,000
Free Float
29,663,000
Market Cap
$205.06 million
Optionable
Optionable
Beta
0.66

Social Links

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:PROF) was last updated on 10/8/2025 by MarketBeat.com Staff
From Our Partners